IBEX develops a product suite to improve clinical decision-making and to streamline pathology laboratory workflows.
Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis, and machine learning, and apply it to cancer diagnostics in digital pathology.Today, Ibex is a multidisciplinary team comprised of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2022 | Debt Financing | $10M | 6 | Kreos Capital | — | Detail |
Mar 9, 2021 | Series B | $38M | 5 | 83North Octopus Ventures | — | Detail |
Mar 26, 2019 | Series A | $11M | 4 | aMoon Fund | — | Detail |
Mar 1, 2017 | Seed | $2.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kreos Capital | Yes | Debt Financing |
83North | — | Debt Financing |
aMoon Fund | — | Debt Financing |
Dell Technologies Capital | — | Debt Financing |
Octopus Ventures | — | Debt Financing |
Planven Entrepreneur Ventures | — | Debt Financing |
Kamet | — | Series A |